White Coat Sciences is a CLIA-certified molecular laboratory developing advanced diagnostics for women's health and innovative medical devices. They create solutions to reduce post-operative infections and prevent catheter-associated urinary tract infections.
Funding
Funding not disclosed
Founders
Product
Problem
The development and deployment of advanced diagnostic testing and medical devices face challenges in specialized areas like women's health and infection control. Existing solutions may not adequately address the specific needs for preventing surgical site infections or catheter-associated urinary tract infections.
Solution
White Coat Sciences operates as a CLIA-certified molecular laboratory focused on diagnostic testing and medical device innovation. The company is developing novel solutions targeting women's health, including diagnostics for gynecological infections, and medical devices aimed at reducing post-operative infections through improved surgical closure techniques. Additionally, they are creating advanced catheter devices designed to mitigate the incidence of nosocomial urinary infections. White Coat Sciences also engages in strategic partnerships with biotechnology firms to accelerate the advancement of new healthcare products and services.
Target Audience
The primary customers are healthcare providers, biotechnology firms, and medical device developers seeking specialized diagnostic capabilities and innovative medical device solutions.
Features
- CLIA-certified molecular laboratory for high-complexity diagnostic testing.
- Development of medical devices for women's health, including diagnostics for cervical cancer and STDs.
- Creation of surgical closure devices engineered to decrease post-operative infection rates.
- Innovation in catheter device design to prevent catheter-associated urinary tract infections.
- Collaboration with biotechnology companies for joint product and service development.